Gallery
Company Bio
GlycoScoreDx is changing the future of prostate cancer diagnosis, with a simple blood test enabling accurate early detection of aggressive prostate cancer.
PORTFOLIO
Healthy Ageing
Interested in becoming a part of our portfolio?
GlycoScoreDx is changing the future of prostate cancer diagnosis, with a simple blood test enabling accurate early detection of aggressive prostate cancer.
You can also contact individual team members on their mobile.
Join our community of like-minded investors, individuals and businesses committed to building a better tomorrow.
Get the latest insights on impact investing, global innovation and scaling your business – delivered straight to your inbox.
Northstar Ventures Limited is authorised and regulated in the UK by the Financial Conduct Authority. Northstar Ventures is not responsible for the content of external internet sites. Northstar Ventures Limited is a limited company registered in England and Wales with company number 0510 4995. Registered office: 5th Floor, Maybrook House, 27-35 Grainger Street, Newcastle upon Tyne, NE1 5JE.
Designed and Built by Layers Studo